<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Problems of Virology</journal-id><journal-title-group><journal-title xml:lang="en">Problems of Virology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы вирусологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0507-4088</issn><issn publication-format="electronic">2411-2097</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">385</article-id><article-id pub-id-type="doi">10.36233/0507-4088-2020-65-3-126-131</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">RETRACTED: High-throughput sequencing in diagnostics and prevention of herpes simplex virus infection (Herpesviridae, Alphaherpesvirinae, Simplexvirus, Human alphaherpesvirus 1)</article-title><trans-title-group xml:lang="ru"><trans-title>СТАТЬЯ ОТОЗВАНА: Высокопродуктивное секвенирование в диагностике и профилактике инфекции простого герпеса (Herpesviridae, Alphaherpesvirinae, Simplexvirus, Human alphaherpesvirus 1)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3407-2224</contrib-id><name-alternatives><name xml:lang="en"><surname>Sergeyev</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Сергеев</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Oleg V. Sergeyev, Doct. Sci. (Biol.), Professor at the Department of microbiology, virology and immunology</p><p>Moscow, 119991</p></bio><bio xml:lang="ru"><p>Сергеев Олег Витальевич, д-р биол. наук, проф. каф. микробиологии, вирусологиии иммунологии </p><p>119991, Москва</p></bio><email>osergeyev123@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4789-4964</contrib-id><name-alternatives><name xml:lang="en"><surname>Bosh’ian</surname><given-names>R. E.</given-names></name><name xml:lang="ru"><surname>Бошьян</surname><given-names>Р. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Roman E. Bosh’ian</p><p>Moscow, 119991</p></bio><bio xml:lang="ru"><p>119991, Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9909-3598</contrib-id><name-alternatives><name xml:lang="en"><surname>Barinsky</surname><given-names>I. F.</given-names></name><name xml:lang="ru"><surname>Баринский</surname><given-names>И. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Igor F. Barinsky</p><p>Moscow, 123098</p></bio><bio xml:lang="ru"><p>123098, Москва</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный исследовательский центр эпидемиологии и микробиологии имени почётного академика Н.Ф. Гамалеи» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-07-22" publication-format="electronic"><day>22</day><month>07</month><year>2020</year></pub-date><volume>65</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>126</fpage><lpage>131</lpage><history><date date-type="received" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Sergeyev O.V., Bosh’ian R.E., Barinsky I.F.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Сергеев О.В., Бошьян Р.Е., Баринский И.Ф.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Sergeyev O.V., Bosh’ian R.E., Barinsky I.F.</copyright-holder><copyright-holder xml:lang="ru">Сергеев О.В., Бошьян Р.Е., Баринский И.Ф.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://virusjour.crie.ru/jour/article/view/385">https://virusjour.crie.ru/jour/article/view/385</self-uri><abstract xml:lang="en"><p><ext-link ext-link-type="uri" xlink:href="/jour/manager/files/Doc/%D0%A3%D0%B2%D0%B5%D0%B4%D0%BE%D0%BC%D0%BB%D0%B5%D0%BD%D0%B8%D0%B5_signed1.pdf"><bold>RETRACTED</bold></ext-link></p><p>Herpes simplex viruses types 1 (HSV-1) and 2 (HSV-2) are among the most common viruses in the human population. The clinical manifestations of HSV infection vary widely, which necessitates reliable molecular methods for the timely diagnosis of herpes virus infection, as well as for detection of mutations in the genes responsible for drug resistance. PCR is often unable to detect HSV isolates with nucleotide substitutions at the primer binding site. Sanger sequencing of the whole genome reveals mutations mainly at the consensus level, which accumulate at advanced stages of viral infection. High-throughput sequencing (HTS, next generation sequencing) offers an obvious advantage both in early diagnosis of herpes virus infection and identification of HSV variants.</p></abstract><trans-abstract xml:lang="ru"><p><ext-link ext-link-type="uri" xlink:href="/jour/manager/files/Doc/%D0%A3%D0%B2%D0%B5%D0%B4%D0%BE%D0%BC%D0%BB%D0%B5%D0%BD%D0%B8%D0%B5_signed1.pdf"><bold>СТАТЬЯ ОТОЗВАНА</bold></ext-link></p><p>Вирусы простого герпеса (ВПГ) 1-го (ВПГ-1) и 2-го (ВПГ-2) типа относятся к числу наиболее распространённых в человеческой популяции. Клинические проявления простого герпеса широко варьируют, что обусловливает необходимость разработки надёжных молекулярных методов для своевременной диагностики герпесвирусной инфекции, а также для обнаружения мутаций в генах, отвечающих за лекарственную устойчивость. Применение ПЦР часто неспособно идентифицировать изоляты ВПГ с заменами нуклеотидов в участке связывания праймеров. Полногеномное секвенирование по Сэнгеру выявляет мутации в основном на консенсусном уровне, они накапливаются уже на продвинутой стадии вирусной инфекции. Высокопродуктивное секвенирование (секвенирование следующего поколения) имеет явные преимущества как в ранней диагностике герпесвирусной инфекции, так и в идентификации вариантов ВПГ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>herpes simplex virus</kwd><kwd>molecular diagnostics</kwd><kwd>genome</kwd><kwd>variability</kwd><kwd>high­throughput sequencing</kwd><kwd>HTS</kwd><kwd>next generation sequencing</kwd><kwd>whole genome sequencing</kwd><kwd>PCR</kwd><kwd>metagenomics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирус простого герпеса</kwd><kwd>молекулярная диагностика</kwd><kwd>геном</kwd><kwd>вариабельность</kwd><kwd>высокопродуктивное секвенирование</kwd><kwd>HTS</kwd><kwd>секвенирование следующего поколения</kwd><kwd>полногеномное секвенирование</kwd><kwd>ПЦР</kwd><kwd>метагеномный анализ</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. WHO. Fact sheet. Herpes simplex virus. Available at: https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Looker K.J., Magaret A.S., Turner K.M.E., Vickerman P., Gottlieb S.L., Newman L.M. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PloS One. 2015; 10(1): el14989. DOI: http://doi.org/10.1371/journal.pone.0114989</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Corey L., Wald A., Celum C.L., Quinn T.C. The effects of herpes simplex virus-2 on HIV-l acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 2004; 35(5): 435-45. DOI: http://doi.org/10.1097/00126334-200404150-00001</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Knipe D.M., Howley P. Fields Virology. New York: Lippincott Williams &amp; Wilkins; 2013.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Behjati S., Tarpey P.S. What is next generation sequencing? Arch. Dis. Child. Educ. Pract. Ed. 2013; 98(6): 236-8. DOI: http://doi.org/10.1136/archdischild-2013-304340</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Handelsman J. Metagenomics: application of genomics to uncultured microorganisms. Microbiol. Mol. Biol. Rev. 2004; 68(4): 669- 85. DOI: http://doi.org/10.1128/MMBR.68.4.669-685.2004</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Deurenberg R.H., Bathoorn E., Chlebowicz M.A., Couto N., Ferdous M., Garcia-Cobos S., et al. Application of next generation sequencing in clinical microbiology and infection prevention. J. Biotechnol. 2017; 243: 16-24. DOI: http://doi.org/10.1016/j.jbiotec.2016.12.022</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Buchman T.G., Simpson T., Nosal C., Roizman B., Nahmias A.J. The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann. NY Acad. Sci. 1980; 354: 279-90. DOI: http://doi.org/10.1111/j.1749-6632.1980.tb27972.x</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Szpara M.L., Gatherer D., Ochoa A., Greenbaum B., Dolan A., Bowden R.J., et al. Evolution and diversity in human herpes simplex virus genomes. J. Virol. 2014; 88(2): 1209-27. DOI: http://doi.org/10.1128/JVI.01987-13</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Renzette N., Gibson L., Bhattacharjee В., Fisher D., Schleiss M.R., Jensen J.D., et al. Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet. 2013; 9(9): e1003735. DOI: http://doi.org/10.1371/journal.pgen.1003735</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Sanjuán R., Domingo-Calap P. Mechanisms of viral mutation. Cell. Mol. Life Sci. 2016; 73(23): 4433-48. DOI: http://doi.org/10.1007/s00018-016-2299-6</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Drake J.W., Hwang C.B.C. On the mutation rate of herpes simplex virus type I. Genetics. 2005; 170(2): 969-70. DOI: http://doi.org/10.1534/genetics.104.040410</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Szpara M.L., Tafuri Y.R., Parsons L., Shamim S.R., Verstrepen K.J., Legendre M., et al. A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses. PLoS Pathog. 2011; 7(10): 1-23. DOI: http://doi.org/10.1371/journal.ppat.1002282</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Pandey U., Bell A.S., Renner D.W., Kennedy D.A., Shreve J.T., Cairns C.L., et al. DNA from dust: comparative genomics of large DNA viruses in field surveillance samples. mSphere. 2016; 1(5): e00132-16. DOI: http://doi.org/10.1128/mSphere.00132-16</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Pandey U., Renner D.W., Thompson R.L., Szpara M.L., Sawtell N.M. Inferred father-to-son transmission of herpes simplex virus results in near-perfect preservation of viral genome identity and in vivo phenotypes. Sci. Rep. 2017; 7(1): 13666. DOI: http://doi.org/10.1038/s41598-017-13936-6</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Morfin F., Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol. 2003; 26(1): 29-37. DOI: http://doi.org/10.1016/s1386-6532(02)00263-9</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Fujii H., Kakiuchi S., Tsuji M., Nishimura H., Yoshikawa T., Yamada S., et al. Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation. J. Virol. Methods. 2018; 251: 123-8. DOI: http://doi.org/10.1016/j.jviromet.2017.10.019</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Somasekar S., Lee D., Rule J., Naccache S.N., Stone M., Busch M.P., el al. Viral surveillance in serum samples from patients with acute liver failure by metagenomic next-generation sequencing. Clin. Infect. Dis. 2017; 65(9): 1477-85. DOI: http://doi.org/10.1093/cid/cix596</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Mercier-Darty M., Boutolleau D., Lepeule R., Rodriguez C., Burrel S. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations. Antiviral Res. 2018; 151: 20-3. DOI: http://doi.org/10.1016/j.antiviral.2018.01.008</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Houldcroft C.J., Bryant J.M., Depledge D.P., Margetts B.K., Simmonds J., Nicolaou S., et al. Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus. Front. Microbiol. 2016; 7: 1317. DOI: http://doi.org/10.3389/fmicb.2016.01317</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Bowden R., Sakaoka H., Donnelly P., Ward R. High recombination rate in herpes simplex virus tyре 1 natural populations suggests significant co-infection. Infect. Genet. Evol. 2004; 4(2): 115-23. DOI: http://doi.org/10.1016/j.meegid.2004.01.009</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Lee S.W., Markham P.F., Coppo M.J., Legione A.R., Markham J.F., Noormohammadi A.H., et al. Attenuated vaccines can recombine to form virulent field viruses. Science. 2012; 37(6091): 188. DOI: http://doi.org/10.1126/science.1217134</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. Lee K., Kolb A.W., Sverchkov Y., Cuellar J.A., Craven M., Brandt C.R. Recombination analysis of herpes simplex virus 1 reveals a bias toward GC content and the inverted repeat regions. J. Virol. 2015; 89(14): 7214-23. DOI: http://doi.org/10.1128/JVI.00880-15</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24. Kolb A.W., Lee K., Larsen I., Craven M., Brandt C.R. Quantitative trait locus based virulence determinant mapping of the HSV-1 genome in murine ocular infection: genes involved in viral regulatory and innate immune networks contribute to virulence. PLoS Pathog. 2016; 12(3): e1005499. DOI: http://doi.org/10.1371/journal.ppat.1005499</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. Koelle D.M., Norberg P., Fitzgibbon M.P., Russell R.M., Greninger A.L., Huang M.L., et al. Worldwide circulation of HSV-2 x HSV- 1 recombinant strains. Sci. Rep. 2017; 7: 44084. DOI: http://doi.org/10.1038/srep44084</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. Javier R.T., Sedarati F., Stevens J.G. Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science. 1986; 234(4777): 746-8. DOI: http://doi.org/10.1126/science.3022376</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27. Lassalle F., Depledge D.P., Reeves M.B., Brown A.C., Christiansen M.T., Tutill H.J., et al. Islands of linkage in an ocean of pervasive recombination reveals two-speed evolution of human cytomegalovirus genomes. Virus Evol. 2016; 2(1): vew017. DOI: http://doi.org/10.1093/ve/vew017</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28. Kriesel J.D., Bhatia A., Thomas A. Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects. Hum. Genome Var. 2014; 1: 14024. DOI: http://doi.org/10.1038/hgv.2014.24</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29. Thompson R.L., Williams R.W., Kotb M., Sawtell N.M. A forward phenotypically driven unbiased genetic analysis of host genes that moderate herpes simplex virus virulence and stromal keratitis in mice. PLoS One. 2014; 9(3): e92342. DOI: http://doi.org/10.1371/journal.pone.0092342</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30. Shipley M.M., Renner D.W., Ott M., Bloom D.C., Koelle D.M., Johnston C., et al Genome-wide surveillance of genital herpes simplex virus type 1 from multiple anatomic over time. J. Infect. Dis. 2018; 218(4): 595-605. DOI: http://doi.org/10.1093/infdis/jiy216</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31. Kleinstein S.E., Shea P.R., Allen A.S., Koelle D.M., Wald A., Goldstein D.B. Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun. 2018; 20(2): 112-20. DOI: http://doi.org/10.1038/s41435-018-0013-4</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32. Johnston C., Koelle D.M., Wald A. Current status and prospects for development of an HSV vaccine. Vaccine. 2014; 32(14): 1553-60. DOI: http://doi.org/10.1016/j.vaccine.2013.08.066</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33. Newman R.M., Lamers S.L., Weiner B., Ray S.C., Colgrove R.C., Diaz F., et al. Genome sequencing and analysis of geographically diverse clinical isolates of herpes simplex virus 2. J. Virol. 2015; 89(16): 8219-32. DOI: http://doi.org/10.1128/JVI.01303-15</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34. Johnston С., Magaret A., Roychoudhury P., Greninger A.L., Reeves D., Schiffer J., et al. Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: a nested cross-sectional viral genotyping study. PLoS Med. 2017; 14(12): e1002475. DOI: http://doi.org/10.1371/journal.pmed.1002475</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35. Anderson T.P., Werno A.M., Beynon K.A., Murdoch D.R. Failure to genotype herpes simplex virus by real-time PCR assay and melting curve analysis due to sequence variation within probe binding sites. J. Clin. Microbiol. 2003; 41(5): 2135-7. DOI: http://doi.org/10.1128/jcm.41.5.2135-2137.2003</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36. Wald A., Corey L. Persistence in the population: epidemiology, transmission. In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37. Sataoka H., Saheki Y., Uzuki K., Nakakita T., Saito H., Sekine K., et al. Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J. Clin. Microbiol. 1986; 24(1): 36-40.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38. Gutiérrez S., Michalakis Y., Blanc S. Virus population bottlenecks during within-host progression and host-to-host transmission. Curr. Opin. Virol. 2012; 2(5): 546-55. DOI: http://doi.org/10.1016/j.coviro.2012.08.001</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39. Nakamura K., Oshima T., Morimoto T., Ikeda S., Yoshikawa H., Shiwa Y., et al. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res. 2011; 39(13): e90. DOI: http://doi.org/10.1093/nar/gkr344</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40. Greninger A.L., Roychoudhury P., Xie H., Casto A., Cent A., Pepper G., et al. Ultrasensitive capture of human herpes simplex virus genomes directly from clinical samples reveals extraordinarily limited evolution in cell culture. mSphere. 2018; 3(3): e00283-18. DOI: http://doi.org/10.1128/mSphereDirect.00283-18</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41. Guan H., Shen A., Lv X., Yang X., Ren H., Zhao Y., et al. Detection of virus in CSF from the cases with meningoencephalitis by next-generation sequencing. J. Neurovirol. 2016; 22(2): 240-5. DOI: http://doi.org/10.1007/s13365-015-0390-7</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42. Naccache S.N., Federman S., Veeeraraghavan N., Zaharia M., Lee D., Samayoa E., et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 2014; 24(7): 1180-92. DOI: http://doi.org/10.1101/gr.171934.113</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43. Oliver G.R., Hart S.N., Klee E.W. Bioinformatics for clinical next generation sequencing. Clin. Chem. 2015; 61(1): 124-35. DOI: http://doi.org/10.1373/clinchem.2014.224360</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44. Parsons L.R., Tafuri Y.R., Shreve J.T., Bowen C.D., Shipley M.M., Enquist L.W., et al. Rapid genome assembly and comparison decode intrastrain variation in human alphaherpesviruses. mBio. 2015; 6(2): e02213-14. DOI: http://doi.org/10.1128/mBio.02213-14</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45. Wan Y., Renner D.W., Albert I., Szpara M.L. VirAmp: a galaxy-based viral genome assembly pipeline. Gigascience. 2015; 4: 19. DOI: http://doi.org/10.1186/s13742-015-0060-y</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46. Lavezzo E., Barzon L., Toppo S., Palù G. Third generation sequencing technologies applied to diagnostic microbiology: benefits and challenges in applications and data analysis. Expert. Rev. Mol. Diagn. 2016; 16(9): 1011-23. DOI: http://doi.org/10.1080/14737159.2016.1217158</mixed-citation></ref></ref-list></back></article>
